Learning objectives: Hereditary ATTR amyloidosis treatment.
Advances in gene editing therapy.
Session date:
04/26/2022 - 12:00pm to 1:00pm CDT
Location:
Virtual/P-117
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Julian Gillmore, MD, PhD, FRCP, FRCPath